Trial · NCT02540434
Outcomes14
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 14 of 14
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Intraoperative Blood Transfusion Total | Procedure length, the average for participants is approximately 6 hours | Only 2 subjects out of total enrolled were randomized. Due to this only 2 subjects being randomized and the study being terminated before completion, no data analysis was done to assess the primary outcome. Therefore there is no measurable data for the mean and SD in either arm. | ||
| SECONDARY | 24-hour Blood Transfusion Total | 24 hours | Trial terminated prior to the collection of this data due to feasibility issues preventing completion of recruitment | ||
| SECONDARY | Fibrinogen Repletion | Procedure length, the average for participants is approximately 6 hours | Trial terminated prior to the collection of this data due to feasibility issues preventing completion of recruitment | ||
| SECONDARY | Incidence of Zero Transfusions | 24 hours | Trial terminated prior to the collection of this data due to feasibility issues preventing completion of recruitment | ||
| SECONDARY | Correction of Microvascular Bleeding | ~30 min intraoperatively | Trial terminated prior to the collection of this data due to feasibility issues preventing completion of recruitment | ||
| SECONDARY | CTICU Length of Stay | Length of Hospital Stay, the average for participants is approximately 7 days | Trial terminated prior to the collection of this data due to feasibility issues preventing completion of recruitment | ||
| SECONDARY | Hospital Length of Stay | Length of Hospital Stay, the average for participants is approximately 7 days | Trial terminated prior to the collection of this data due to feasibility issues preventing completion of recruitment | ||
| SECONDARY | Thrombosis and Transfusion Reactions | Length of Hospital Stay, the average for participants is approximately 7 days | Trial terminated prior to the collection of this data due to feasibility issues preventing completion of recruitment | ||
| SECONDARY | Infection and Respiratory Failure | Length of Hospital Stay, the average for participants is approximately 7 days | Trial terminated prior to the collection of this data due to feasibility issues preventing completion of recruitment | ||
| SECONDARY | Blood Loss | Length of Hospital Stay, the average for participants is approximately 7 days, | Trial terminated prior to the collection of this data due to feasibility issues preventing completion of recruitment | ||
| SECONDARY | Incidence of Re-exploration | Length of Hospital Stay, the average for participants is approximately 7 days | Trial terminated prior to the collection of this data due to feasibility issues preventing completion of recruitment | ||
| SECONDARY | Mortality Rate | Length of Hospital Stay, the average for participants is approximately 7 days | Trial terminated prior to the collection of this data due to feasibility issues preventing completion of recruitment | ||
| SECONDARY | Correlation of Laboratory and ROTEM Data | Procedure length, the average for participants is approximately 6 hours | Trial terminated prior to the collection of this data due to feasibility issues preventing completion of recruitment | ||
| SECONDARY | Time to Product Administration | Procedure length, the average for participants is approximately 6 hours | Trial terminated prior to the collection of this data due to feasibility issues preventing completion of recruitment |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02540434/outcomes